LaborDr.Merk - Labor Dr. Merk in Ochsenhausen, Germany
Labor Dr.Merk, Lab Dr.Merk, Laboratory Dr.Merk, Laboratory Ochsenhausen, Laboratory Germany, contract research organization Germany, contract development and manufacturing organization Germany, CRO Germany, CRO Ochsenhausen, CDMO Germany, pharmaceutical industry, pharmaceutical industry ochsenhausen, pharmaceutical industry germany, medical device manufactures, contract manufactuig, biosafety testing, vaccine retesting, european market, testing of efficacy of disinfectans, bioassay development, R&D, GMP approved facilities labor germay, expert teams labor germany, lab europe, CRO europe, CMO europe
5
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-5,cookies-not-set,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-13.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Welcome at Labor Dr. Merk & Kollegen GmbH

As a CRO and CDMO we offer comprehensive know-how for the pharmaceutical industry and for medical device manufacturers.
Whether you are looking for services in contract manufacturing, biosafety testing, vaccine retesting for the European market, testing of efficacy of disinfectants, bioassay development or a strong partner for your R&D project – we’ve got you covered! Relying on over 40 years of experience, our GMP approved facilities and our expert teams we will support you.

Services

Besides our services in contract manufacturing, Labor Dr. Merk & Kollegen GmbH offers a wide range of testing services in the fields of virology, microbiology, immunology and toxicology.

Manufacturing

As a full CDMO with end-to-end process development, manufacturing with analytical characterization and regulatory support, Labor Dr. Merk & Kollegen GmbH also offers process GMP manufacturing of viral gene therapeutics, oncolytic viral therapeutics and vaccines.

Services

Besides our services in contract manufacturing, Labor Dr. Merk & Kollegen GmbH offers a wide range of testing services in the fields of virology, microbiology, immunology and toxicology.

Manufacturing

As a full CDMO with end-to-end process development, manufacturing with analytical characterization and regulatory support, Labor Dr. Merk & Kollegen GmbH also offers process GMP manufacturing of viral gene therapeutics, oncolytic viral therapeutics and vaccines.

Development

As a CRO and CDMO with more than 40 years of relevant experience, Labor Dr. Merk & Kollegen GmbH is a strong partner for your R&D projects.

Company

Since 1971, Labor Dr. Merk & Kollegen GmbH has evolved into a diversified testing laboratory and CDMO. We provide process development and GMP manufacturing of viral gene therapeutics, oncolytic viral therapeutics and vaccines, as well as testing services in virology, microbiology, immunology.

Development

As a CRO and CDMO with more than 40 years of relevant experience, Labor Dr. Merk & Kollegen GmbH is a strong partner for your R&D projects.

Company

Since 1971, Labor Dr. Merk & Kollegen GmbH has evolved into a diversified testing laboratory and CDMO. We provide process development and GMP manufacturing of viral gene therapeutics, oncolytic viral therapeutics and vaccines, as well as testing services in virology, microbiology, immunology.

Career

Do you enjoy working in small project teams with flat hierarchies? We are always looking for motivated people to join our team!

Contact

Do you have a question or want to work with us? Then please don’t hesitate to contact us via phone, email or using the form below. We will be in touch as soon as possible!

Career

Do you enjoy working in small project teams with flat hierarchies? We are always looking for motivated people to join our team!

Contact

Do you have a question or want to work with us? Then please don’t hesitate to contact us via phone, email or using the form below. We will be in touch as soon as possible!

Testimonials

read more

News

FDA inspection successfully passed

 

In September 2018 LMK successfully passed an extensive inspection by the FDA. We owe this success to our highly competent and professional staff. The authority’s expectations were met in full, after assessing LMK’s laboratory facilities and quality assurance system against strict cGMP standards. In the closing meeting the FDA inspector emphasized his appreciation for LMK’s comprehensive and coherent data as well as for our well established procedures to secure data integrity.
Labor Dr. Merk & Kollegen GmbH holds long lasting excellent expertise in biosafety testing of products from pharmaceutical industries or medical device manufacturers. Especially in the fields of virological and microbiological testing as well as cell based bioassays a wide range of GMP and GLP compliant methods for preclinical and clinical studies or quality control of final products are available.
The company is expanding their business by offering R&D services for process development and GMP manufacturing of oncolytic viruses, viral vaccines and viral vectors. This expansion is supported by the European Regional Development Fund (ERDF).
FDA Inspektion

Erfolgreicher Abschluss der FDA Inspektion

Diesen Monat konnte eine umfangreiche Inspektion durch die FDA erfolgreich abgeschlossen werden. Dieses hervorragende Ergebnis ist sowohl der Professionalität als auch der hohen fachlichen Kompetenz der Mitarbeiter zu verdanken. Da sowohl die Labore wie auch die im Hause etablierten Qualitätssicherungssysteme vollumfänglich den hohen cGMP Standards entsprachen, wurden die Erwartungen der Behörde voll und ganz erfüllt. Besonders hervorgehoben wurde die Gesamtheit und Korrektheit der erhobenen Daten und die etablierte Vorgehensweises zur Sicherung der Datenintegrität.
Labor Dr. Merk & Kollegen GmbH holds long lasting excellent expertise in biosafety testing of products from pharmaceutical industries or medical device manufacturers. Especially in the fields of virological and microbiological testing as well as cell based bioassays a wide range of GMP and GLP compliant methods for preclinical and clinical studies or quality control of final products are available.
The company is expanding their business by offering R&D services for process development and GMP manufacturing of oncolytic viruses, viral vaccines and viral vectors. This expansion is supported by the European Regional Development Fund (ERDF).

Our customer